Live Breaking News & Updates on High unmet medical needs

Stay updated with breaking news from High unmet medical needs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT

Clinical Data Abstract Presentation; IP Portfolio of 9 Patents; Phase 3 Cancer Treatments: RenovoRx NASDAQ: RNXT $RNXT
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Orlando , Florida , United-states , Salt-lake-city , Utah , Miami , France , Paris , France-general , Saclay , Bermuda , California

Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)

Biopharma Company Issues New Patent Application; Phase 3 Clinical Trials for Cancer Treatments: RenovoRx (NASDAQ: RNXT)
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

Orlando , Florida , United-states , Bermuda , Miami , California , Paris , France-general , France , Saclay , Michaelj-pishvaian , Frontpagestocks-corporateads

Adaptimmune Therapeutics PLC: Adaptimmune Reports Positive Data in its SURPASS Trial; Outlines Plans for Advanced Clinical Development in Multiple MAGE-A4 Positive Solid Tumors

- 44% Objective Response Rate (ORR) with a single dose of ADP-A2M4CD8 in 25 heavily pre-treated patients with late-stage ovarian, urothelial, and head & neck cancers Further clinical development planned ....

Canada , United-kingdom , Colombo , Western , Sri-lanka , Texas , United-states , Philadelphia , Pennsylvania , Emaase , Schleswig-holstein , Germany